Table 3 Comparison of characteristics between CC, CT, and TT.

From: An association study of C9orf3, a novel component of the renin-angiotensin system, and hypertension in diabetes

Characteristics

CC

CT

TT

Number

247

119

16

Gender (male)—%

62.3

52.1

68.8

Age (≥ 65 years)—%

40.5

40.3

18.8

BMI (≥ 25)—%a

36.4

34.7

43.8

FPG—mg/dLb

153.1 ± 54.3

159.8 ± 83.0

162.3 ± 78.6

Glycosylated hemoglobin—%b

7.5 ± 1.4

7.7 ± 1.8

8.2 ± 1.7

eGFR—mL/min/1.73 m2b

78.8 ± 26.6

72.3 ± 23.4d

79.7 ± 36.4

U-Alb/Cr ratio—mg/g CREc

23.6 (9.3–67.5)

18.6 (7.8–119.3)

52.5 (11.3–188.8)

PRA—ng/mL/hc

0.60 (0.30–1.10)

0.80 (0.50–1.70)d

1.05 (0.90–1.30)d

Angiotensin II—pg/mLc

9.0 (6.0–14.0)

9.0 (6.0–14.0)

12.0 (8.3–19.5)

PAC—pg/mLb

81.6 ± 41.2

84.9 ± 35.2

81.7 ± 30.3

  1. FPG fasting plasma glucose, eGFR estimated glomerular filtration rate, U-Alb/Cr ratio urine albumin-to-creatinine ratio, PRA plasma renin activity, PAC plasma aldosterone concentration.
  2. aBody Mass Index (BMI) is the weight in kilograms divided by square of the height in meters.
  3. bValues are means ± SD.
  4. cValues shown are medians (interquartile ranges).
  5. dp < 0.05 for the comparison with CC.